Meatosis
PrivateLast Round
Accelerator
Apr 2, 2023
Company Overview
Meatosis operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was an Accelerator round in April 2023.
Meatosis is an agriculture and food technology company that develops lab-grown fish cell lines for the production of cultivated seafood products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meatosis Comparables
Compare Meatosis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sea2Cell | 88% | |
| Forsea | 87% | |
| Umami Bioworks | 85% |
For institutional investors. Book with your work email.
Meatosis Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Meatosis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2023
Received funding from MassChallenge Israel and Modern Agriculture Foundation.
For institutional investors. Book with your work email.
Meatosis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Meatosis's valuation, stock price, and market status.
Is Meatosis a public or private company?
Meatosis is a private company.
What is the current stock price of Meatosis?
Meatosis is a private company, so its shares have no public market price. Caplight tracks Meatosis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Meatosis worth (valuation)?
Valuation information for Meatosis is not publicly available.
Can I buy Meatosis stock?
Meatosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Meatosis's last funding round?
Meatosis's most recent funding round was Accelerator on April 2, 2023.
Who are the main investors in Meatosis?
Key investors in Meatosis include MassChallenge Israel.
Will Meatosis IPO soon?
No public IPO plans have been announced for Meatosis.
How can I track Meatosis secondary market activity?
Caplight tracks bids, offers, and trades in Meatosis's shares on secondary markets.